The Cancer Drug Development Forum – CDDF is the platform for all stakeholders involved in the development of cancer drugs.

CDDF 11th Spring Conference 2020

Current and Future Challenges of Innovative Oncology Drugs Development

Noordwijk aan Zee, Netherlands – 10-12 February 2020



The Cancer Drug Development Forum (CDDF) Spring conference 2020 is a unique forum that convenes every 18 months and gathers the leaders in the world of innovative cancer therapy development, including medical researchers, pharmaceutical industry representatives, and regulatory authority representatives. Patient representation is also pursued. It is the successor of the former CDDF Alpine Conference and the 11th edition takes place from 10 to 12 February 2020, in Noordwijk aan Zee (NL) which is a sea-side village, 30 minutes from the Amsterdam Schiphol Airport.

This multi-stakeholder, interactive meeting offers plenary lectures with moderated discussions, including case studies and networking opportunities. The programme focuses on the latest and future challenges of Innovative oncology drug development with a special emphasis on rational combination therapies, tumor agnostic drug development, cell therapy, and the new EMA Anti-cancer Guideline.


The target is a multidisciplinary audience of representatives from academia, EU and US Regulatory Bodies (EMA, FDA, National Agencies), the pharmaceutical Industry, HTAs and patient advocates.


  • Jaap Verweij (CDDF Board)
  • Stefan Schwoch (Lilly)
  • Irmela Radtke (Roche)
  • Paul Stockman (Astrazeneca)



Radisson Blu Palace Hotel, Noordwijk aan Zee
Pickeplein 8,
2202 CL Noordwijk,
The Netherlands

More information will be available soon.

Cancer Drug Development Forum
c/o BLSI
Clos Chapelle-aux-Champs 30
1200 Brussels, Belgium
Tel: +32 2 880 62 70

Legal address
c/o Deloitte Tirol
Wirtschaftsprüfungs GmbH,
Wilhelm-Greil-Str. 15,
6020 Innsbruck, Austria